Ebola

Tulane gets $12M for Lassa fever animal studies

Tulane gets $12M for Lassa fever animal studies

Tulane University scientists will get $12 million for animal studies to test drug combinations to treat Lassa fever and to develop a vaccine for the deadly virus, which can attack internal organs and cause bleeding from the mouth, nose and other places.

Tulane's medical school says a team led by Robert Garry is getting grants from the National Institutes of Health for two five-year studies.

One, getting $5.7 million, will evaluate a drug mixture to treat the virus, which is common in parts of West Africa. The other will provide $6.3 million to develop a vaccine based on a recently discovered possible target for antibodies on the surface of the virus, a news release Tuesday...

81°